Maintenance / Service
PRODUCTS
-
On-site labs with our own personnel offer greater control of samples and timelines, minimizing risk for our customers.
-
At the core of our comprehensive eClinical platform, iMednet EDC is uniquely designed to help sponsors and CROs achieve their clinical research goals. Highly flexible, it enables you to build studies quickly, while easily adapting to complex protocols and mid-study changes with ease.
-
The power of the analytical laboratory is its data. However, converting vast amounts of data into actionable decisions that provide confidence to business-critical operations is extremely challenging.
-
Conduct secure video based visits, manage study schedules, and keep participants connected through a single unified platform.
-
The quality assurance (QA) team ensures the highest standards from pre-clinical to market by focusing on operational quality control, quickly identifying potential issues, and implementing necessary changes.
WHITE PAPERS AND CASE STUDIES
-
Quantitation Of Monoclonal Antibodies In Serum
Monoclonal antibodies (mAbs) are a rapidly growing group of targeted therapeutics. Gain insight into the importance of optimized bioanalytical assay platforms for mAb development.
-
Designing, Selecting, And Developing Bioconjugates For Clinical Success
Accelerate the development of complex bioconjugates to unlock new possibilities for targeted therapies and advance the next generation of precision medicine.
-
Digital Transformation Optimizes Production, Quality, And Compliance
Discover how advanced automation solutions at Fermion's new facility were implemented to enhance production, quality, and compliance in pharmaceutical manufacturing while meeting industry standards.
-
How AI Is Unlocking Healthcare Data To Transform Prostate Cancer Treatment
As the global reliance on algorithms and artificial intelligence (AI) continues to grow, the importance of data quality and completeness has become a critical concern.
-
Powering More Efficient Clinical Development With AI And ML
Explore how AI and ML are revolutionizing clinical trials by automating data processes to accelerate research and transform data into actionable outcomes for patient care.
-
Addressing The Data Integrity Challenge
Learn how ProPharma streamlined operations and enhanced data integrity for a leading pharmaceutical company through expert process harmonization and strategic guidance.
-
The True ROI Of Decentralized Clinical Trials
Gain a greater understanding of how the right DCT solution, or combination of solutions, coupled with clear metrics and expert guidance on execution, can demonstrate tangible, quantitative ROI in clinical trials.
-
Digital Biomanufacturing, Now: From Digital Dreamer To Digital Doer
Discover how digital biomanufacturing is revolutionizing drug production by exploring strategies for integrating digital technologies to enhance efficiency and innovation in bioprocessing workflows.
-
If You Can't Win The Game, Change It
Explore how eData sharing is used in the biopharma market, enabling standardized, collaborative supply chains that reduce risks and enhance visibility while improving capacity planning.
-
2025 Trends In Patient Recruitment: From Disruption To Precision
Explore the four macro trends reshaping the recruitment space in 2025—each grounded in emerging data, technology, and behavior shifts.
-
Digitalizing Batch Records In Pharmaceutical Production
Pharma manufacturing embraces cutting-edge automation, yet outdated paper-based documentation hinders efficiency and delays batch releases. See how digital solutions can transform compliance.
-
Electronic Batch Reporting
Learn how a CDMO automatically created a comprehensive batch report model to drive their reporting and speed root cause identification of quality failures with an Industrial DataOps software solution.
NEWS
-
Sutro Biopharma And Boehringer Ingelheim BioXcellence™ Collaboration: Established First-In-Class Cell-Free Capabilities At Commercial Scale1/7/2025
Boehringer Ingelheim BioXcellence™ and Sutro Biopharma Inc. today announced that they successfully applied Sutro’s proprietary cell-free expression technology on a commercial scale to manufacture luveltamab tazevibulin (luvelta), Sutro’s Tubulin FRα-targeting antibody-drug conjugate (ADC) designed to treat a broad range of patients with ovarian cancer and other FRα expressing cancers.
-
Hyland Unveils Powerful Cloud And AI Innovations That Streamline Content And Agentic Automation Across Industries11/24/2025
Hyland is accelerating innovation with the Content Innovation Cloud, delivering cutting-edge solutions that empower organizations to embrace AI, streamline operations, and drive business success.
-
Deloitte Launches AI Solution Suite To Help Organizations Enhance Their Human And Machine Workforce6/24/2025
Deloitte announced the launch of its Human Capital AI solution suite, featuring Workforce Analyzer and Workforce Planner+.
-
Cloudbeds And Sabre Hospitality Announce Strategic Partnership To Streamline Hotel Reservations And Optimize Distribution2/25/2025
Cloudbeds, the innovative leader in hospitality management technology, has today announced a strategic partnership with Sabre Hospitality, a leading global travel technology company.
-
AlphaMeld Corporation Expands Collaboration With Kyowa Kirin For Enterprise-Wide Access To Drug Discovery Platform1/28/2025
AlphaMeld Corporation, a global leader in the application of artificial intelligence (AI), machine learning (ML), and generative AI tools to revolutionize drug discovery and development, today announced the continuation and expansion of its collaboration with Kyowa Kirin Co., Ltd. (Kyowa Kirin), a Japan-based global specialty pharmaceutical company.